Executive Summary
Concise overview of sample identity, tests performed, key results, and final biological safety conclusion for rapid regulatory review and internal stakeholders.
A well-constructed Biocompatibility Testing Report provides auditable evidence of safety decisions, supports regulatory submissions, and helps align product development with applicable standards. It reduces review cycles and clarifies next-step controls for manufacturing and clinical teams.
Teams in regulatory affairs, quality assurance, R&D, and clinical affairs commonly create or review biocompatibility reports.
External reviewers, notified bodies, and contract manufacturers also depend on consistent report structure and traceable data to validate decisions.
Concise overview of sample identity, tests performed, key results, and final biological safety conclusion for rapid regulatory review and internal stakeholders.
Detailed description of the device/component, material composition, lot numbers, manufacturing process references, and any finished-device or extract information necessary for traceability.
List of standards and protocols (for example ISO 10993 parts) with laboratory method IDs, acceptance criteria, and deviations documented for reproducibility.
Raw data, summarized findings, statistical analyses, and observed effects presented in tables and figures with units and limits of detection.
Discussion that links test results to biological relevance, risk assessment conclusions, and whether additional testing or controls are required.
Chain-of-custody records, certificates of analysis, instrument calibration logs, and lab accreditation statements (for example ISO/IEC 17025).
| Field | Configuration |
|---|---|
| Author | Required; editable until submission |
| Reviewer | Sequential approval; optional comments |
| Approver | Final sign-off; required signature |
| Attachments | Appendices locked after approval |
Choose a platform that preserves audit trails, supports required authentication, and retains records in compliance with regulations.
Ensure the chosen system meets any applicable standards such as 21 CFR Part 11 for FDA-regulated records and maintains retention capabilities.
1–7 business days depending on lab backlog
2–8 weeks depending on test complexity
2–5 business days after data finalization
3–10 business days for crossfunctional review
Allocate at least 2–4 weeks for responses and corrections
| Criteria | Biocompatibility Testing Report | Safety Data Sheet (SDS) |
|---|---|---|
| Primary Purpose | biological safety evidence | hazard communication |
| Regulatory Focus | fda/iso testing | osha/reach/clp compliance |
| Typical Content | methods, raw data, interpretation | handling, storage, hazards |
| Use Case | 510(k)/technical dossier | user and workplace safety |
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | No | No | Yes, limited | Yes, limited |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |
A medical device developer submitted sample extracts for cytotoxicity and sensitization testing
An implantable component showed unexpected leachables in screening assays